Control of TH17/Treg balance by hypoxia-inducible factor 1

  • Eric V. Dang
  • , Joseph Barbi
  • , Huang Yu Yang
  • , Dilini Jinasena
  • , Hong Yu
  • , Ying Zheng
  • , Zachary Bordman
  • , Juan Fu
  • , Young Kim
  • , Hung Rong Yen
  • , Weibo Luo
  • , Karen Zeller
  • , Larissa Shimoda
  • , Suzanne L. Topalian
  • , Gregg L. Semenza
  • , Chi V. Dang
  • , Drew M. Pardoll*
  • , Fan Pan
  • *Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

1363 Scopus citations

Abstract

T cell differentiation into distinct functional effector and inhibitory subsets is regulated, in part, by the cytokine environment present at the time of antigen recognition. Here, we show that hypoxia-inducible factor 1 (HIF-1), a key metabolic sensor, regulates the balance between regulatory T cell (T reg) and TH17 differentiation. HIF-1 enhances T H17 development through direct transcriptional activation of RORγt and via tertiary complex formation with RORγt and p300 recruitment to the IL-17 promoter, thereby regulating TH17 signature genes. Concurrently, HIF-1 attenuates Treg development by binding Foxp3 and targeting it for proteasomal degradation. Importantly, this regulation occurs under both normoxic and hypoxic conditions. Mice with HIF-1α-deficient T cells are resistant to induction of T H17-dependent experimental autoimmune encephalitis associated with diminished TH17 and increased Treg cells. These findings highlight the importance of metabolic cues in T cell fate determination and suggest that metabolic modulation could ameliorate certain T cell-based immune pathologies.

Original languageEnglish
Pages (from-to)772-784
Number of pages13
JournalCell
Volume146
Issue number5
DOIs
StatePublished - 02 09 2011

Fingerprint

Dive into the research topics of 'Control of TH17/Treg balance by hypoxia-inducible factor 1'. Together they form a unique fingerprint.

Cite this